Home » Topics » BioWorld

BioWorld
RSS

ONCOSCINT APPROVED IN ITALY

Jan. 15, 1992

ELAN AGREES TO ACQUIRE VEGA

Jan. 15, 1992

ALPHA-BETA BEGINS FIRST TRIALS

Jan. 15, 1992

ENZO STOCK CONTINUES TO RISE

Jan. 15, 1992

ZYNAXIS FILES FOR 2 MILLION-SHARE IP0

Jan. 15, 1992

START-UP FOCUSES ON TRANSCRIPTION FACTORS

Jan. 15, 1992

NIH CONTRACTS WITH MORE LAW FIRMS

Jan. 14, 1992

MEDAREX FILES IND FOR MAb

Jan. 14, 1992

GI Expects R&D To Keep It in the Red

Jan. 14, 1992

INTERNEURON GETS RIGHTS TO COMPOUNDS

Jan. 14, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...